FDA NDC Directory · JSON-LD · Markdown

Lunsumio

NDC 50242-142 · HUMAN PRESCRIPTION DRUG · CONCENTRATE

Generic nameMosunetuzumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761263
Dosage form / routeCONCENTRATE · INTRAVENOUS
Active ingredientsMOSUNETUZUMAB (30 mg/30mL)
Marketing started20221222
Package count1

External sources

Source: openFDA. Public-domain (CC0).